Fig. 1From: Learn from antibody–drug conjugates: consideration in the future construction of peptide-drug conjugates for cancer therapyAntibody–drug conjugate strategy significantly improves the antitumoral efficacy. A ADCs exhibit superior tumor targeting in the circulation compared with cocktail therapy. B Three main components of an ADC include antibody, linker, and payloadBack to article page